BTAL: Market Neutral Vs Recent Market Shocks

I am downgrading my rating from BUY to HOLD on BTAL due to recent performance divergence and risk exposure. My RSI-based entry strategy from prior coverage was invalidated by holding distribution shifts and market evolution since mid-2025. Today, BTAL could hedge against the risk of a tech sector repricing, fueled by market fears regarding the Kospi.

Seeking Alpha • Jul 19, 2026

Bitcoin's high conviction holders are turning into sellers as the crypto's price hits new lows

In the past two days, bitcoin's highest conviction holders have sold about $2.4 billion in bitcoin. Of the bitcoin sold in the past 30 days, 26% came from investors who bought it above $90,000.

CNBC • Jun 3, 2026

Real Assets or Active ETFs? Where RIAs Allocate

Registered investment advisors did not pull back on exchange-traded funds in the first quarter of 2026. They kept adding them, according to AdvizorPro's Q1 2026 Quarterly RIA ETF Trends Report.

ETF Trends • May 26, 2026

BTAL: Mea Culpa (Rating Downgrade)

The AGF US Market Neutral Anti-Beta Fund ETF is downgraded from 'Buy' to 'Hold' after significant underperformance and failure to hedge in 2026. BTAL's structure remains sector-neutral, shorting high-beta stocks and going long low-beta names, but poor individual stock selection led to negative -13.9% returns this year. Despite correct macro positioning, BTAL's active management failed to deliver intended negative beta exposure or effective downside protection in 2026.

Seeking Alpha • Apr 23, 2026

Strategists at Exchange on Navigating the New Correlation Regime

For years, the standard 60/40 portfolio relied on a simple inverse relationship between equities and bonds. However, as volatility spikes, that safety net is fraying, and panelists at Exchange discussed responses to this challenge.

ETF Trends • Mar 17, 2026

5 ETFs Hovering Around a One-Month High

Commodity and defensive ETFs surged as Iran war tensions rattled markets, pushing several funds close to one-month highs.

Zacks Investment Research • Mar 10, 2026

BTAL: A Negative Beta Fund As A Portfolio Hedge

AGF U.S. Market Neutral Anti-Beta Fund ETF (BTAL) excels as a tactical hedge, not a traditional buy-and-hold investment. BTAL monetizes the spread between low and high beta stocks, thriving in risk-off or overextended market environments. The ETF is delta-neutral by sector, reducing portfolio volatility and drawdowns, and improves Sharpe ratio when paired with equities.

Seeking Alpha • Jan 17, 2026

Are Anti-Beta ETFs Like BTAL Worth Owning In 2026?

When high-beta stocks stumble and markets turn volatile, AGFiQ U.S. Market Neutral Anti-Beta Fund ( NYSEARCA:BTAL ) is designed to deliver.

24/7 Wall Street • Jan 1, 2026

BTAL: Unconvincing Long-Short ETF

AGF U.S. Market Neutral Anti-Beta Fund (BTAL) is long in 200 low-beta stocks and short in 200 high-beta stocks. BTAL has value characteristics and low company risk, but its track record is uncompelling, with negative return since 2011. FTLS stands out as a superior long-short ETF alternative for investors seeking risk-adjusted performance.

Seeking Alpha • Oct 24, 2025

BTAL: A Smart, Yet Controversial Hedge To The S&P 500

BTAL offers a market-neutral strategy by going long low-beta and short high-beta U.S. stocks, providing S&P 500 hedging. The ETF plays the low vs. high beta spread, offering stronger short-term hedging and better long-term preservation than classic shorts. In my view, it must be included in a portfolio with a clear strategy; otherwise, it's dead weight, not added value.

Seeking Alpha • Jun 23, 2025